The Centers for Disease Control and Prevention (CDC) released a new guideline on Saturday that states people with underlying health conditions can receive a coronavirus vaccine.
The orientation explains that “adults of any age with certain underlying medical conditions are at increased risk for serious COVID-19 virus-related illnesses.
Thus, the CDC added that those vaccines that have been approved by the Food and Drug Administration (FDA) “it can be given to people with underlying medical conditions as long as they have not had a severe allergic reaction to any of the vaccine ingredients. ”
The CDC explained that people with a weakened immune system due to other diseases or medications may also receive a COVID-19 vaccine, but they should be aware that there is limited safety data on the effects of vaccines on these people. .
In addition, although people with HIV were included in clinical trials, safety data from this group are not yet available.
The CDC also stated in its Saturday guide that people with autoimmune conditions could get the vaccine, although no data is currently available on vaccine safety in this demographic.
Those who have experienced Guillain-Barre syndrome, a condition in which the body begins to attack parts of its own nervous system, can also receive vaccine doses. The guide adds that after vaccination during clinical trials, there were no cases of syndrome.
People who have previously experienced Bell’s palsy, a condition that causes muscle weakness on one side of the face, may also receive a vaccine. Some participants during clinical trials developed Bell’s palsy after vaccination, but it did not occur at a faster rate than expected in the general population.
Despite the start of distribution of Pfizer / BioNTech and Moderna vaccines, the CDC recommends that people who get vaccinated continue to follow current coronavirus safety and health protocols, such as wearing a mask, socially distancing themselves, and avoiding agglomerations.
According to the CDC, almost 2 million people they have received the first dose of coronavirus vaccine since Saturday. Both the vaccine developed by Pfizer and BioNTech and that of Moderna require two doses to be administered several weeks apart.
Although data from the final trial of the two vaccines showed that they had an approximate 95% efficacy rate in the prevention of COVID-19 The Moderna vaccine has an efficacy rate of 86% for those over 65 years of age.
Healthcare workers have been prioritized in the initial distribution of the vaccine and the CDC Advisory Committee on Immunization Practices (ACIP) voted last week advise the CDC to include those essential front-line workers aged 75 and over, including emergency assistants and teachers, in the next phase of coronavirus vaccination.